16 CFR § 1702.10 - Human experimental data involving the testing of human subjects.

---
identifier: "/us/cfr/t16/s1702.10"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "16 CFR § 1702.10 - Human experimental data involving the testing of human subjects."
title_number: 16
title_name: "Commercial Practices"
section_number: "1702.10"
section_name: "Human experimental data involving the testing of human subjects."
chapter_name: "CONSUMER PRODUCT SAFETY COMMISSION"
subchapter_number: "E"
subchapter_name: "POISON PREVENTION PACKAGING ACT OF 1970 REGULATIONS"
part_number: "1702"
part_name: "PETITIONS FOR EXEMPTIONS FROM POISON PREVENTION PACKAGING ACT REQUIREMENTS; PETITION PROCEDURES AND REQUIREMENTS"
positive_law: false
currency: "2026-04-05"
last_updated: "2026-04-05"
format_version: "1.1.0"
generator: "[email protected]"
authority: "15 U.S.C. 1471(4), 1472, 1474, 1269(a), 2079(a); 21 U.S.C. 371(a)."
regulatory_source: "45 FR 13064, Feb. 28, 1980, unless otherwise noted."
cfr_part: "1702"
---


# 1702.10 Human experimental data involving the testing of human subjects.

Any human experimental data submitted with a petition requesting an exemption under this part shall include a statement establishing that adequate measures have been taken to ensure against psychological or physical injury to the subject of the human studies. The Commission considers its regulations concerning the protection of human subjects (16 CFR part 1028) to be an example of measures that are adequate to ensure against psychological or physical injury to human subjects.